Economic status and clinical care in young type 1 diabetes patients: a nationwide multicenter study in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
31
Tipo de produção
article
Data de publicação
2013
Editora
SPRINGER-VERLAG ITALIA SRL
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
GOMES, Marilia B.
MATHEUS, Alessandra Saldanha de Mattos
CALLIARI, Luis Eduardo
LUESCHER, Jorge Luiz
COBAS, Roberta A.
COELHO, Wellington Siqueira
TSCHIEDEL, Balduino
RAMOS, Alberto Jose
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ACTA DIABETOLOGICA, v.50, n.5, p.743-752, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of this study is to evaluate the influence of economic status on clinical care provided to Brazilian youths with type 1 diabetes in daily practice, according to the American Diabetes Association's guidelines. This was a cross-sectional, multicenter study conducted between 2008 and 2010 in 28 public clinics in Brazil. Data were obtained from 1,692 patients (55.3 % female, 56.4 % Caucasian), with a mean age of 13 years (range, 1-18), a mean age at diagnosis of 7.1 +/- A 4 years and diabetes duration of 5 +/- A 3.7 years. Overall, 75 % of the patients were of a low or very low economic status. HbA1c goals were reached by 23.2 %, LDL cholesterol by 57.9 %, systolic blood pressure by 83.9 % and diastolic blood pressure by 73.9 % of the patients. In total, 20.2 % of the patients were overweight and 9.2 % were obese. Patients from very low economic status were less likely to attend tertiary care level when compared with those from low, medium and high economic status, 64.2 % versus 75.5 % versus 78.3 % and 74.0 %; p < 0.001, respectively. The rate of annual screening for retinopathy, nephropathy and for foot alterations was 66.2, 69.7 and 62.7 %, respectively. Insulin dose, age, very low economic status, daily frequency of self-blood glucose monitoring and female gender were independently associated with poor glycemic control. Screening for diabetic complications and attaining glucose, lipid and blood pressure goals present a challenge for young Brazilian type 1 diabetes patients. The low economic status of the majority of our patients may represent a barrier to reaching these goals.
Palavras-chave
Type 1 diabetes, Chronic complications, Diabetes in youths
Referências
  1. ABEP, 2010, BRAZ EC CLASS CRIT
  2. American Diabetes Association, 2011, DIABETES CARE S1, V34, pS11, DOI [10.2337/dc11-S011, DOI 10.2337/DC11-S011]
  3. Anderson B, 1997, J PEDIATR, V130, P257, DOI 10.1016/S0022-3476(97)70352-4
  4. Ceriello A, 2007, DIABETES CARE, V30, P649, DOI 10.2337/dc06-2048
  5. Dahl-Jørgensen K, 1987, Acta Endocrinol Suppl (Copenh), V284, P1
  6. Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349
  7. Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x
  8. Green A, 2000, LANCET, V355, P873
  9. Fagulha Ana, 2004, Acta Med Port, V17, P173
  10. FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499
  11. Galler A, 2011, DIABETES CARE, V34, P2356, DOI 10.2337/dc11-0838
  12. Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008
  13. Gomes MB, 2009, DIABETES RES CLIN PR, V85, P61, DOI 10.1016/j.diabres.2009.04.016
  14. Grundy SM, 1999, CIRCULATION, V100, P1134
  15. Helgeson VS, 2011, PEDIATR DIABETES, V12, P25, DOI 10.1111/j.1399-5448.2010.00663.x
  16. Hood KK, 2011, PEDIATRICS, V124, P1171
  17. IBGE Diretoria de Pesquisas, COORD TRAB REND PESQ
  18. Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6
  19. MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509
  20. Margeirsdottir HD, 2008, DIABETOLOGIA, V51, P554, DOI 10.1007/s00125-007-0921-8
  21. Muhlhauser I, 1998, DIABETOLOGIA, V41, P1139, DOI 10.1007/s001250051043
  22. Nathan DM, 2005, NEW ENGL J MED, V353, P2643
  23. Negrato CA, 2012, DIABETIC MED, V29, P1142, DOI 10.1111/j.1464-5491.2012.03590.x
  24. Negrato CA, 2010, J ENDOCRINOL INVEST, V33, P373, DOI 10.3275/6439
  25. Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374
  26. Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161
  27. Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025
  28. Purnell JQ, 1998, JAMA-J AM MED ASSOC, V280, P140, DOI 10.1001/jama.280.2.140
  29. Rodriguez BL, 2010, J PEDIATR-US, V157, P245, DOI 10.1016/j.jpeds.2010.02.021
  30. Rosilio M, 1998, DIABETES CARE, V21, P1146, DOI 10.2337/diacare.21.7.1146
  31. Schwab KO, 2010, PEDIATR DIABETES, V11, P357, DOI 10.1111/j.1399-5448.2010.00665.x
  32. Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862
  33. Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
  34. Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6
  35. SHAMOON H, 1993, NEW ENGL J MED, V329, P977
  36. Urbach SL, 2005, PEDIATR DIABETES, V6, P69, DOI 10.1111/j.1399-543X.2005.00104.x
  37. van Vliet M, 2010, J PEDIATR-US, V156, P923, DOI 10.1016/j.jpeds.2009.12.017
  38. Zgibor JC, 2005, DIABETES CARE, V28, P521, DOI 10.2337/diacare.28.3.521
  39. Ziegler R, 2011, PEDIATR DIABETES, V12, P11, DOI 10.1111/j.1399-5448.2010.00650.x